Biosense Webster launches latest generation of Carto heart mapping system


Johnson & Johnson Medical Devices Companies has today announced the launch of Biosense Webster’s Carto 3 system version 7 and the Carto Prime mapping module. This represents the most advanced version of the Carto 3 system, the company’s three-dimensional (3D) heart mapping system.

The Carto Prime mapping module adds tools to the Carto 3 platform for further addressing all major complex arrhythmias, with improvements in mapping capabilities that help to reduce ablation times, compared to standard mapping algorithms, the company said in a press release.

“This technology has a full package of EP mapping solutions to help get clear and accurate visualisations of almost every type of complex arrhythmia,” said Vias Markides, consultant cardiologist and Heart Division Director at Royal Brompton Hospital, London, UK. “Features like Cartofinder, LAT Hybrid and Parallel Mapping are significant improvements in mapping capabilities and make this a transformative step in technology.”

The Carto Prime mapping module is a fully integrated solution that incorporates these powerful tools:

  • Coherent Mapping may simplify the diagnosis of scar-related complex atrial arrhythmia by applying physiological constraints on local activation times (LAT) information. In a multicentre study (n=60), Coherent Mapping significantly reduced the ablation time required for arrhythmia termination in comparison with ablation guided by standard mapping algorithm.
  • Cartofinder expands the CARTO 3 System mapping capabilities to irregular atrial arrhythmia, identifying repetitive focal and rotational activations.
  • Parallel Mapping allows for simultaneous mapping of different arrhythmia using the same catheter locations.
  • LAT Hybrid provides increased location accuracy compared with standard premature ventricular complex (PVC) mapping by associating the PVC map LAT information to its corresponding Normal Sinus Rhythm location.

“Carto Prime is the most important software release since the introduction of Carto 3,” said Elad Anter, associate section head, Electrophysiology at Cleveland Clinic, Cleveland, USA. “Coherent Mapping helps to overcome many of the challenges in electro-anatomical mapping of complex arrhythmias, and with Parallel Mapping, we’re able to map different rhythms simultaneously.”

“The launch of Carto 3 system version 7 and the Carto Prime mapping module reflects our collaborative efforts with physicians to identify pressing clinical needs and then integrate innovative technologies into our platform to address them,” said Uri Yaron, worldwide president of Biosense Webster. “This release benefits patients and the EP community by helping make the complex – simple. Together with physicians, we’re transforming treatment for cardiac arrythmias.”


Please enter your comment!
Please enter your name here